Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“Had a great session at the Multisplinacry PCD monthly meeting (9/4)
By Ellen Ogbonna, Jordan Snyder myself
Guided by JK (Jeries Kort)
Topic: Talquetmab in Active PCD
• exploring its future use in AL Amyloidosis
Exciting insights and discussions ahead for patients and care.”
More from Al-Ola Abdallah on OncoDaily.
